AAHKS 2024: Multicenter RCT of HXLPE vs. Conventional PE in 500 Primary TKAs at 10 Years .
Multicenter Randomized Clinical Trial of HXLPE vs. Conventional PE in 500 Primary TKAs at 10 Years
Five hundred eighteen patients undergoing primary total knee arthroplasty were randomized to receive highly cross-linked polyethylene (HXLPE) tibial inserts (n=264) or conventional ultra-high-molecular-weight polyethylene (UHMWPE) tibial inserts (n=254). The primary outcome of interest was implant survivorship free from revision or reoperation. Secondary outcomes included revision indications, radiographic results, and clinical outcomes. Outcomes were assessed over a mean follow-up period of 11 years. Overall, the results revealed no significant differences between groups in revision or reoperation rates, with 10-year survivorships of 96% (HXLPE) and 94% (UHMWPE). Notably, no wear-related failures or fractures occurred in the HXLPE group, while one case of osteolysis occurred in the UHMWPE group. These findings suggest equivalent long-term performance of HXLPE and UHMWPE in primary TKAs, with potentially lower wear-related risks for HXLPE.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics